Evidence map›Paper›PMID 35916516›Full record

ArticleAntimicrobial agents and chemotherapy2022

Intrinsically High Resistance of Candida glabrata to Hydrogen Peroxide and Its Reversal in a Fluconazole-Resistant Mutant.

Tom Edlind, Santosh Katiyar

Abstract readLetter
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tom EdlindMicrobiType LLC, Wyndmoor, Pennsylvania, USA.
Santosh KatiyarDrexel University College of Medicine, Philadelphia, Pennsylvania, USA.

Funding

Candida glabrata Pdr1: Master Regulator of Azole ResistanceR01AI073794 · NIAID · DREXEL UNIVERSITY · PI EDLIND, THOMAS D · 2008 to 2011
$1.4M
Polymorphism: Antifungal Drug Resistance & Adaptation in CandidaR21AI121821 · NIAID · DREXEL UNIVERSITY · PI KATIYAR, SANTOSH KUMAR · 2016 to 2017
$391k
NIAID NIH HHS R01 AI073794NIAID NIH HHS R21 AI121821
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Candida glabrataFluconazoleAzolesDrug Resistance, FungalHydrogen PeroxideAzolesFluconazoleHydrogen Peroxideazole resistanceCandida glabratacatalasefluconazolehydrogen peroxidePdr1

Identifiers

PMID35916516
PMCPMC9487529

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.